Urinary Incontinence Products Market Size, Share, Growth, and Industry Analysis, By Type (Male Slings, Artificial Urinary Sphincters, Urinary Catheters, Electrical Stimulation Devices, Male Adult Diapers) By Application (Hospital, Ambulatory Surgery Centers, Home Health, Other) Regional Forecast From 2026 To 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

URINARY INCONTINENCE PRODUCTS MARKET OVERVIEW

The global Urinary Incontinence Products Market is valued at about USD 5.12 Billion in 2026 and is projected to reach USD 12.8 Billion by 2035. It grows at a compound annual growth rate (CAGR) of around 10.73% from 2026 to 2035.

The urinary incontinence products market covers absorbent garments, catheters, surgical implants and neuromodulation devices that help people manage involuntary loss of urine. The condition affects women more often than men because of childbirth, menopause and pelvic floor weakness. In men, prostate surgery and an enlarged prostate remain common causes. Male adult diapers account for 38% of the urinary incontinence products market by type, which shows how strongly consumers prefer non-invasive solutions. Manufacturers now focus on discreet designs, skin-friendly materials, intermittent catheter technology and minimally invasive surgical options. Hospitals, ambulatory surgery centers and home care providers are widening access to treatment.

The United States remains the most mature national arena for urinary incontinence products, shaped by a large aging population, high diagnosis rates and strong retail availability of adult briefs and underwear. Medicare coverage rules for catheters and supplies, along with private insurance support for surgical procedures, influence purchasing patterns across hospital and home settings. Consumers increasingly look for discreet, gender-specific absorbent products. Urologists and urogynecologists adopt male slings, artificial urinary sphincters and tibial nerve stimulation for patients who do not respond to conservative care. Online pharmacies and subscription delivery services also make products easier to obtain, which supports steady adoption across the country.

KEY FINDINGS

LATEST TRENDS

Smart absorbent products are among the most visible trends in the urinary incontinence products market. Manufacturers now embed moisture sensors in briefs and bed pads so caregivers receive alerts and change garments only when required. This protects skin and reduces labor time in nursing facilities. Sustainability is another strong direction, with producers testing bio-based fluff pulp, plant-derived superabsorbent polymers and recyclable packaging to lower the environmental footprint of disposable products. Gender-specific design continues to grow, since male-focused guards and underwear address anatomy and leakage patterns that unisex products often miss. In clinical care, hydrophilic and compact intermittent catheters are gaining preference because they reduce urethral trauma and infection risk. Implantable tibial nerve stimulators are moving therapy away from daily drug treatment.

•   
•   
  

  Download Free Sample to learn more about this report

    

URINARY INCONTINENCE PRODUCTS MARKET SEGMENTATION

By Type

• Male Slings: Male slings hold 11% of the urinary incontinence products market and serve men with mild to moderate stress urinary incontinence, most often after prostatectomy. The device is a mesh or tissue support placed under the urethra during a short outpatient procedure. It gently compresses the urethra to restore continence when abdominal pressure rises. Surgeons prefer slings for patients who want an option without a mechanical pump, and recovery is usually quicker than with larger implants. Demand rises with prostate cancer survivorship, since more men live long after surgery and seek lasting solutions beyond pads. 

• Artificial Urinary Sphincters: Artificial urinary sphincters account for 10% of the market and remain the reference surgical treatment for men with severe stress urinary incontinence. The implant includes an inflatable cuff around the urethra, a pressure-regulating balloon and a pump placed in the scrotum, allowing the patient to open and close the urethra on demand. Because the device offers strong control, it suits men with significant leakage after radical prostatectomy or pelvic radiation. High device and procedure costs limit volume, yet strong clinical outcomes and growing awareness among urologists support steady demand. 

• Urinary Catheters: Urinary catheters represent 27% of the market and cover intermittent, indwelling and external catheters used for retention, neurogenic bladder and overflow incontinence. Intermittent hydrophilic catheters are gaining ground because ready-to-use coatings lower friction, protect the urethra and reduce urinary tract infection risk, which matters for people with spinal cord injury or multiple sclerosis. External condom catheters give men a non-invasive alternative to indwelling devices in hospitals and nursing homes. Reimbursement for intermittent catheter supplies in many countries supports recurring purchases, and compact, discreet designs improve adherence among active users.

• Electrical Stimulation Devices: Electrical stimulation devices hold 14% of the market and include tibial nerve stimulators, sacral neuromodulation systems and pelvic floor stimulators. These products treat urge incontinence and overactive bladder by modulating nerve signals that control bladder activity. They offer an alternative for patients who stop responding to anticholinergic drug or dislike their side effects. Implantable systems with rechargeable batteries and smartphone-based programming are expanding the therapy base, while non-invasive wearable stimulators attract patients who prefer treatment without surgery. Physicians value the reversible, adjustable nature of neuromodulation, and clinical evidence continues to strengthen adoption in urology and urogynecology clinics.

• Male Adult Diapers: Male adult diapers lead the market with 38% share because they offer immediate, non-invasive protection to men at every stage of incontinence. The category includes guards, pull-up underwear, tab-style briefs and pads, with male-specific shaping that places absorbency where leakage occurs. Retail pharmacies, supermarkets and online stores keep these products widely available, and discreet packaging reduces embarrassment during purchase. Institutional buyers in nursing homes and hospitals rely on high-capacity briefs for bedridden patients, creating steady bulk demand. Innovation centers on thinner superabsorbent cores, odor control, breathable backsheets and softer nonwoven fabrics that protect skin. 

By Application

• Hospital: Hospitals hold 33% of the urinary incontinence products market and act as the main setting for diagnosis, urodynamic testing, surgery and acute catheter use. Urologists and urogynecologists perform sling and sphincter implantation here, while nursing teams manage catheters and absorbent products for admitted patients. Purchasing is often handled through group contracts, which favor suppliers with broad portfolios and proven infection control performance. Hospitals focus on reducing catheter-associated infections and pressure injuries, so demand grows for antimicrobial catheter, breathable briefs and skin-protecting products. 

• Ambulatory Surgery Centers: Ambulatory surgery centers account for 14% of the market, supported by the shift of minimally invasive urological procedures to outpatient settings. Male sling placement, bulking procedures and device implantation can often be performed without overnight admission, lowering costs and shortening recovery. Payers encourage this setting because it reduces facility charges, and patients value convenience and lower infection exposure. Centers prefer compact, procedure-ready kits, reliable implants and devices that allow short operating times. 

• Home Health: Home health leads the application landscape with 44% share, reflecting the preference of patients and caregivers for private, comfortable management of incontinence. Absorbent underwear, pads, intermittent catheters, external catheters and wearable stimulators are widely used outside clinical facilities. Aging populations, shorter hospital stays and reimbursement support for catheter supplies strengthen this demand. Online pharmacies and subscription services give users discreet access and regular replenishment, while telehealth helps clinicians guide product selection remotely. 

• Other: The other segment holds 9% of the market and includes nursing homes, rehabilitation centers, long-term care residences and specialty continence clinics. Although smaller than hospital and home use, these settings consume large quantities of high-capacity briefs, bed pads and catheters for residents who need continuous support. Facilities value products that reduce leakage, protect skin and lower caregiver workload, so bulk purchasing agreements are common. Rehabilitation centers also use pelvic floor stimulation and biofeedback devices for patients recovering from stroke, spinal injury or childbirth. 

MARKET DYNAMICS

Driving Factor

Rising prevalence of incontinence among aging populations

Population aging is the strongest force behind demand for urinary incontinence products. About 423 million adults live with incontinence worldwide, and the share of older people keeps rising in developed and emerging economies. Age-related bladder changes, weakened pelvic muscles, diabetes, neurological disease and prostate conditions all increase the likelihood of leakage. Longer life expectancy also means more people live with chronic conditions that require long-term continence care. Better awareness campaigns by healthcare providers and brands have reduced silence around the topic, so more patients seek diagnosis and buy products instead of tolerating symptoms. Nursing homes and assisted living facilities require steady supplies of briefs, pads and catheters, which creates predictable recurring demand for manufacturers and distributors.

Driver Impact Analysis*

Restraining Factor

Social stigma and delayed diagnosis

Many people hide incontinence because of embarrassment, and this delays diagnosis, treatment and product adoption. Patients often assume leakage is a normal part of aging and rely on improvised protection instead of clinically suitable devices. Reluctance to discuss symptoms with physicians reduces referrals for slings, sphincters and neuromodulation therapy, which limits the growth of surgical and device segments. Cultural attitudes in several regions also reduce open advertising and public discussion, which slows consumer education. In addition, limited reimbursement for absorbent products in many countries forces patients to pay out of pocket, so cost-sensitive households choose fewer or lower-quality products. These barriers restrain market penetration even where clinical need is high.

Restraint Impact Analysis*

Growth of home-based and digitally supported continence care

Opportunity

Home health represents 44% of application share, and this creates a major opening for companies that design user-friendly products. Self-catheterization kits, discreet absorbent underwear, wearable stimulators and app-guided pelvic floor trainers all fit the preference for private, convenient care. Telehealth allows clinicians to assess symptoms remotely and recommend suitable products, while subscription delivery models improve adherence and reduce stockouts.

Emerging economies offer further potential as incomes rise, retail pharmacy networks expand and awareness improves. Manufacturers that combine clinical credibility with consumer-friendly packaging, education and online ordering can reach untreated patients who currently avoid clinics. 

Product complications and environmental pressure

Challenge

Catheter-associated urinary tract infections, implant erosion, device malfunction and skin irritation remain concerns that affect physician confidence and patient satisfaction. Regulatory scrutiny of surgical mesh products has made approval pathways more demanding and raised litigation risk for manufacturers. At the same time, disposable absorbent products create large volumes of landfill waste, and regulators and retailers are asking for greener materials.

Raw material costs for pulp, polymers and nonwovens fluctuate, squeezing margins in price-sensitive channels. Companies must therefore invest in safer designs, antimicrobial coatings, recyclable materials and clinical evidence while keeping products affordable, which increases development costs and lengthens launch timelines.

•   
•   
  Download Free Sample to learn more about this report

    

URINARY INCONTINENCE PRODUCTS MARKET REGIONAL INSIGHTS

• North America

North America holds 37% of the urinary incontinence products market, making it the leading region. About 25 million adults in the United States experience urinary incontinence, which sustains demand for absorbent products, catheters and surgical devices. Strong awareness, high diagnosis rates and established retail brands such as Depend and Poise keep consumer purchases high. Medicare and private insurers cover many catheter supplies and surgical procedures, which supports adoption of slings, sphincters and neuromodulation systems. The region also hosts major manufacturers and clinical research centers that introduce new technologies early. Canada adds steady demand through public healthcare coverage and an aging population. 

• Europe

Europe accounts for 28% of the market, supported by an older population profile and well-organized public healthcare systems. About 1 in 5 Europeans is aged 65 or older, which sustains demand for incontinence care in nursing homes, hospitals and homes. Germany, the United Kingdom, France, Italy and the Nordic countries lead adoption of intermittent catheters, pelvic floor therapy and absorbent products, and many national health systems reimburse continence supplies. Environmental regulation pushes manufacturers toward recyclable packaging and bio-based materials, which shapes product development in the region. Strong clinical guidelines encourage early diagnosis and conservative treatment before surgery. 

• Asia Pacific

Asia Pacific holds 22% of the market and is the most dynamic region for volume growth. Japan is one of the oldest societies in the world, with about 29% of residents aged 65 and above, and it leads regional use of premium adult diapers. China has about 15% of its population in that age group, and rising incomes, urbanization and online retail are expanding consumer access. Local manufacturers such as Hengan Group, Unicharm and Chiaus compete with global brands through affordable pricing and wide distribution. India, South Korea and Southeast Asian countries are also seeing greater awareness and healthcare investment. 

• Middle East & Africa

Middle East and Africa represents 7% of the market, with demand centered on Gulf countries, Turkey, Israel and South Africa. Diabetes affects about 1 in 6 adults in the Middle East and North Africa region, and the condition raises the risk of bladder dysfunction and incontinence. Government investment in hospitals and specialty clinics in Saudi Arabia and the United Arab Emirates supports adoption of catheters and surgical devices. Premium absorbent products are sold mainly through pharmacies and modern retail in urban areas. Elsewhere in Africa, low awareness, limited insurance coverage and price sensitivity restrict use, with many patients relying on basic cloth or low-cost pads. 

• Rest of the World

Rest of the World holds 6% of the urinary incontinence products market and includes Latin America and other smaller territories. Brazil is the largest national contributor, where about 15% of residents are aged 60 and above, which increases demand for adult briefs and catheters. Mexico, Argentina and Chile add demand through expanding private healthcare and modern retail pharmacy chains. Public health systems provide limited reimbursement, so out-of-pocket spending shapes purchasing and favors affordable absorbent products. Surgical treatment and neuromodulation remain concentrated in major urban hospitals. Global manufacturers are strengthening distributor relationships, offering education programs for clinicians and introducing value-priced product lines to reach price-sensitive consumers across the region.

KEY INDUSTRY PLAYERS

The urinary incontinence products market is competitive, with global hygiene groups, medical device manufacturers and regional absorbent producers all participating. Major vendors such as Kimberly-Clark, SCA, Procter & Gamble, Coloplast, ConvaTec, Hollister and Medtronic compete through brand strength, clinical credibility and broad distribution. Asia-based companies including Unicharm, Hengan Group and Chiaus expand through competitive pricing and local retail reach. Emerging players focus on niche segments such as sustainable absorbents, wearable stimulators and compact catheters. Competitive strategies include product launches, acquisitions, hospital contracts, partnerships with distributors and investment in nonwoven technology. Positioning increasingly depends on skin health, discreet design, infection prevention and the ability to serve both institutional and home care customers.

List of Top Urinary Incontinence Products Companies

• Flexicare Medical
• Cotton Incorporated
• Medline
• Hollister
• Domtar
• ConvaTec
• First Quality Enterprises
• Marlen Manufacturing & Development
• Tranquility
• Kimberly-Clark
• Coloplast
• Medtronic
• Coco
• Fuburg
• SCA
• Hengan Group
• Procter & Gamble
• B Braun
• 3M
• Unicharm
• AAB Group
• Chiaus

LEADER INSIGHTS

• Coloplast: Lars Rasmussen, Interim President and CEO, outlined the company’s five-year Impact4 strategy, emphasizing customer-focused innovation, technology adoption, and improved user experiences as key priorities for long-term growth. The strategy identifies opportunities to expand Chronic Care offerings, strengthen market penetration, and improve patient access through reimbursement developments and innovative healthcare solutions. (Published: September 2, 2025 | Source: https://www.coloplast.com/)

• Kimberly-Clark: Mike Hsu, Chairman and Chief Executive Officer at the time of the announcement, highlighted rising demand for the company’s consumer brands, including Depend incontinence products, as a driver of investment in North American manufacturing capacity and innovation. The planned investment of more than USD 2 billion over five years reflects a strategy to strengthen manufacturing capabilities, support product innovation, and meet consumer demand across its personal care portfolio. (Published: May 1, 2025 | Source: https://www.investor.kimberly-clark.com/)

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment in the urinary incontinence products market is moving toward home-based care, sustainable materials and minimally invasive therapy. Home health holds 44% of application share, so companies are funding consumer-friendly catheters, discreet absorbent lines and direct-to-patient delivery platforms. Acquisitions of specialist device makers allow larger groups to enter urology and neuromodulation segments quickly. Capital is also flowing into nonwoven production lines, bio-based superabsorbents and recyclable packaging to meet retailer and regulatory expectations. Emerging markets offer attractive opportunities through retail expansion and local manufacturing partnerships. Digital health investments, including remote monitoring and app-based pelvic floor training, create additional value for patients, clinicians and payers.

NEW PRODUCT DEVELOPMENT

New product development in the urinary incontinence products market focuses on comfort, infection prevention and connected care. Manufacturers are launching ready-to-use hydrophilic catheters with compact packaging, which improve convenience for people who catheterize several times each day. Absorbent brands introduce gender-specific underwear, softer nonwoven fabrics, faster-acquisition cores and odor-control technology. Implantable tibial and sacral neuromodulation systems now offer rechargeable power and smartphone-based adjustment, which reduces clinic visits. Sensor-enabled briefs alert caregivers when changes are needed, lowering skin damage and labor time. Sustainability is another development priority, with brands testing plant-based materials and recyclable packaging. Male adult diapers hold 38% of type share, so male-specific design remains an important innovation target.

RECENT DEVELOPMENTS

• September 2026 – Convatec launches Cure Aqua hydrophilic catheter for self-catheterization users across the United States and Canada.Convatec expanded its Cure portfolio with a ready-to-use hydrophilic catheter, aiming to widen choice for people who catheterize, using hydrophilic coating technology and user-focused design.

• February 2026 – Coloplast completes Uromedica acquisition to strengthen its urology portfolio for stress urinary incontinence treatment.Coloplast acquired Uromedica to broaden its urology offering, targeting men with stress incontinence through adjustable implant technology and specialist surgical channels, adding organic growth potential.

• June 2026 – Kimberly-Clark expands Depend absorbent underwear range with softer fabrics and improved leak protection for adults.Kimberly-Clark upgraded Depend underwear to strengthen retail leadership, using flexible nonwoven fabrics, superabsorbent cores and gender-specific designs to improve comfort and containment for active adults.

• April 2026 – Medline broadens incontinence care portfolio for hospitals and long-term care facilities with advanced absorbent briefs. Medline enhanced its institutional continence line to support skin health, using breathable backsheets, high-capacity absorbent cores and standardized supply programs across hospital and nursing settings.

REPORT COVERAGE

This report covers the global urinary incontinence products market across 5 product types, 4 application segments and 5 regions. It reviews male slings, artificial urinary sphincters, urinary catheters, electrical stimulation devices and male adult diapers, along with demand in hospitals, ambulatory surgery centers, home health and other settings. The analysis includes market dynamics, latest trends, segmentation, regional outlook, competitive positioning, investment opportunities, new product development and recent developments. It profiles 22 companies, including Kimberly-Clark, SCA, Coloplast, ConvaTec, Hollister and Medtronic, to help manufacturers, investors, distributors and healthcare providers evaluate strategy and growth potential. About 423 million adults live with incontinence worldwide, which underlines the clinical need that the report addresses.